Silo Pharma (SILO) EBIT (2018 - 2026)
Silo Pharma's (SILO) quarterly EBIT came in at -$928949.0 in Q2 2026, up 25.6% year-over-year from -$739621.8 in Q2 2025, and up 41.75% quarter-over-quarter from -$1.6 million in Q1 2026.
Powered by 
Analysis
Silo Pharma (SILO) EBIT (2018 - 2026) Analysis & Trends
Silo Pharma has disclosed EBIT across 9 years of filings, most recently posting -$928949.0 for Q2 2026.
- In Q2 2026, EBIT rose 25.6% year-over-year to -$928949.0; the TTM figure through Jun 2026 stood at -$4.5 million (up 13.64% YoY), while the FY2025 annual figure was -$4.3 million, up 9.03% from the prior year.
- EBIT came in at -$928949.0 for Q2 2026 at Silo Pharma, up from -$1.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$494285.0 in Q2 2022 to a low of -$1.8 million in Q4 2024.
- Average EBIT over 5 years is -$1.1 million, with a median of -$1.0 million recorded in 2024.
- Year-over-year, EBIT sank 125.58% in 2023 and surged 56.63% in 2025.
- Over 5 years, EBIT stood at -$1.7 million in 2022, then rose by 29.77% to -$1.2 million in 2023, then sank by 55.82% to -$1.8 million in 2024, then surged by 56.63% to -$786524.0 in 2025, then declined by 18.11% to -$928949.0 in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$928949.0 in Q2 2026, -$1.6 million in Q1 2026, and -$786524.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.94 Bn | 195.95 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 179.74 Bn | 176.57 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 132.05 Bn | 124.20 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 82.43 Bn | 74.44 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 61.23 Bn | 56.04 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 53.42 Bn | 48.28 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.77 Bn | 30.47 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.62 Bn | 30.33 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -365.99 Mn |
| 10 | Silo Pharma | 2.49 Mn | 2.49 Mn | - | -928,949.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -928,949.00 |
| Mar 31, 2026 | -1.59 Mn |
| Dec 31, 2025 | -786,524.00 |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -1.25 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | -879,513.00 |
| Dec 31, 2023 | -1.16 Mn |
| Sep 30, 2023 | -773,398.00 |
| Jun 30, 2023 | -1.11 Mn |
| Mar 31, 2023 | -803,485.00 |
| Dec 31, 2022 | -1.66 Mn |
| Sep 30, 2022 | -949,154.00 |
| Jun 30, 2022 | -494,285.00 |
| Mar 31, 2022 | -527,259.00 |
| Dec 31, 2021 | -942,416.00 |
| Sep 30, 2021 | -463,942.00 |